Clinical Trial Update: Velocardiofacial (VCFS; 22q11.2; DiGeorge) Syndrome Study

View source ↗

Summary

The sponsor reports completion of a clinical trial studying Velocardiofacial/DiGeorge syndrome (22q11.2 deletion syndrome).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• 22q11 Deletion Syndrome
• Digeorge Syndrome
• Velocardiofacial Syndrome

Snippet

Sponsor: National Institute of Mental Health (NIMH) | Conditions: DiGeorge Syndrome, Velocardiofacial Syndrome | Status: COMPLETED